Skip to main content
. 2021 Jul 21;16(7):e0254809. doi: 10.1371/journal.pone.0254809

Table 1. Characteristics of white, Black, Hispanic, and non-Hispanic patients hospitalized with COVID-19.

White N = 9994 Black N = 4215 Hispanic N = 5761 Non-Hispanic N = 11,269
Age
    Median (IQR) 62 (49, 76) 59 (47, 71) 62 (49, 76) 59 (47, 71)
    18–39 1,432 (14.33) 671 (15.92) 1,198 (20.8) 1,499 (13.3)
    40–49 1,137 (11.38) 556 (13.19) 937 (16.26) 1,227 (10.89)
    50–59 1,846 (18.47) 903 (21.42) 1,236 (21.45) 2,126 (18.87)
    60–69 1,974 (19.75) 919 (21.8) 1,049 (18.21) 2,430 (21.56)
    70–79 1,737 (17.38) 710 (16.84) 684 (11.87) 2,054 (18.23)
    80–89 1,863 (18.64) 453 (10.75) 652 (11.32) 1,927 (17.10)
    ≥90 5 (0.05) 3 (0.07) 5 (0.09) 6 (0.05)
Sex
    Male 5,297 (53.00) 1,994 (47.31) 3,045 (52.86) 5,758 (51.10)
Race
American Indian or Alaska 23 (0.40) 438 (3.89)
Asian or Pacific islander 24 (0.42) 626 (5.56)
Black or African American 80 (1.39) 3,955 (35.10)
Mixed racial group 1 (0.02) 3 (0.03)
Other racial group 1,501 (26.05) 426 (3.78)
Unknown racial group 500 (8.68) 228 (2.02)
White 3,632 (63.04) 5,593 (49.63)
Ethnicity
    Hispanic 3,632 (36.34) 80 (1.90)
BMI
    Median (IQR) 28.9 (25.0, 34.1) 30.7 (26.0, 37.0) 29.3 (25.9, 34.0) 29.2 (24.9, 35.0)
    <25 1,816 (25.49) 778 (20.36) 1,281 (33.62) 2,781 (28.49)
    25–29.9 2,202 (30.91) 983 (25.73) 753 (19.76) 2,509 (25.70)
    ≥30 3,106 (43.6) 2,060 (53.91) 1,776 (46.61) 4,471 (45.80)
ZIP (first digit)*
    0 1,299 (14.97) 670 (16.55) 501 (10.06) 1,766 (16.25)
    1 751 (8.66) 206 (5.09) 217 (4.36) 995 (9.15)
    2 634 (7.31) 1,841 (45.47) 100 (2.01) 2,524 (23.22)
    3 1,654 (19.07) 481 (11.88) 1,289 (25.87) 941 (8.66)
    4 829 (9.56) 314 (7.76) 143 (2.87) 1,076 (9.90)
    5 93 (1.07) 15 (0.37) 22 (0.44) 90 (0.83)
    6 321 (3.7) 82 (2.03) 69 (1.38) 411 (3.78)
    7 797 (9.19) 158 (3.90) 571 (11.46) 484 (4.45)
    8 380 (4.38) 121 (2.99) 244 (4.9) 1,054 (9.70)
    9 1,917 (22.10) 161 (3.98) 1,826 (36.65) 1,528 (14.06)
Insurance
    Uninsured 587 (5.87) 151 (3.58) 557 (9.67) 333 (2.96)
    Medicare 3,098 (31.00) 1,442 (34.21) 807 (14.01) 4,187 (37.16)
    Medicaid 1,042 (10.43) 704 (16.70) 1,022 (17.74) 1,448 (12.85)
    Government 166 (1.66) 78 (1.85) 70 (1.22) 241 (2.14)
    Private 3,185 (31.87) 1,232 (29.23) 1,710 (29.68) 3,274 (29.05)
    Other 239 (2.39) 50 (1.19) 124 (2.15) 267 (2.370)
    Missing 1,677 (16.78) 558 (13.24) 1,471 (25.53) 1,519 (13.48)
Comorbidities
N (%) with comorbidity data available 7,437 (74.41) 3,228 (76.58) 3,857 (66.95) 8,582 (76.16)
    Diabetes 2,114 (28.43) 1,205 (37.33) 1,144 (29.66) 2,783 (32.43)
    Hypertension 3,692 (49.64) 1,940 (60.10) 1,645 (42.65) 4,788 (55.79)
    Heart Failure 1,110 (14.93) 545 (16.88) 398 (10.32) 1,452 (16.92)
    ESRD 273 (3.67) 313 (9.70) 202 (5.24) 500 (5.83)
    COPD 1,036 (13.93) 357 (11.06) 253 (6.56) 1,231 (14.34)
    Asthma 701 (9.43) 414 (12.83) 318 (8.24) 920 (10.72)
    Coronary artery disease 1,517 (20.40) 576 (17.84) 528 (13.69) 1,793 (20.89)

*ZIP: ZIP code data exclude those with missing ZIP code

*p-value for differences by race and ethnicity all <0.001 with two exceptions: difference in coronary artery disease by race p-value was 0.03, and diabetes prevalence difference by ethnicity p-value was 0.002.

IQR = interquartile range, ESRD = end stage renal disease, COPD = chronic obstructive pulmonary disease